Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Endocrine
; 82(1): 161-170, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37351760
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cortisone
/
Cardiovascular Diseases
/
Adrenal Gland Neoplasms
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Endocrine
Journal subject:
ENDOCRINOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: